TheraJect, Inc.
Patent Owner
Stats
- 6 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 13, 2016 most recent publication
Details
- 6 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 662 Total Citation Count
- Jun 25, 2002 Earliest Filing
- 3 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9517205 Soluble needle arrays for delivery of influenza vaccinesAug 19, 11Dec 13, 16[A61K, A61B, A61M]
9381680 Method of manufacturing solid solution perforator patches and uses thereofMay 21, 09Jul 05, 16[B29C, A61B, A61M]
7211062 Solid solution perforator for drug delivery and other applicationsJan 28, 04May 01, 07[A61M]
7182747 Solid solution perforator for drug delivery and other applicationsNov 21, 05Feb 27, 07[A61B]
6945952 Solid solution perforator for drug delivery and other applicationsJun 25, 02Sep 20, 05[A61B]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0316,333 DISSOLVING SOLID SOLUTION PERFORATOR PATCH FOR MIGRAINE TREATMENTAbandonedOct 29, 12Oct 23, 14[A61K, A61M]
2012/0193,840 METHOD OF MANUFACTURING SOLID SOLUTION PERFORATOR PATCHESAbandonedFeb 02, 12Aug 02, 12[B29C]
2009/0035,446 Solid Solution Perforator Containing Drug Particle and/or Drug-Adsorbed ParticlesAbandonedSep 05, 06Feb 05, 09[A61L]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
